Fig. 2
From: In silico design of a multi-epitope vaccine against the triple negative breast cancer
Method of protein vaccine components and arrangement. MHC major histocompatibility complex, HLA human leukocyte antigen, CTL cytotoxic T lymphocyte, HTL helper T lymphocyte.
